Associated Papers
Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4.
Luo J et al.
The Journal of Biological Chemistry, 2022
34973340 (PubMed )
Supplement: mmc1.pdf
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemia.
Gustine JN et al.
British Journal of Haematology, 2021
The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4.
Wang L et al.
Bmc Molecular and Cell Biology, 2021
Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom's Macroglobulinemia.
Milanesi S et al.
International Journal of Molecular Sciences, 2020
New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM.
Scala S et al.
Vaccines, 2020
WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.
Heusinkveld LE et al.
Journal of Clinical Immunology, 2019
WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH et al.
Immunological Reviews, 2019
How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.
Badolato R et al.
Blood, 2017
Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.
Heusinkveld LE et al.
Expert Opinion on Orphan Drugs, 2017
WHIM Syndrome Caused by Waldenström's Macroglobulinemia-Associated Mutation CXCR4 (L329fs).
Liu Q et al.
Journal of Clinical Immunology, 2016
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.
Xu L et al.
British Journal of Haematology, 2016
Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.
Treon SP et al.
Blood, 2014
Select a paper to view details